Effect of Antidepressant Switching vs Augmentation on Remission Among Patients With Major Depressive Disorder Unresponsive to Antidepressant Treatment: The VAST-D Randomized Clinical Trial

Overview of attention for article published in JAMA: Journal of the American Medical Association, July 2017

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (87th percentile)

Mentioned by

news: 30 news outlets
blogs: 4 blogs
policy: 1 policy source
twitter: 90 X users
patent: 1 patent

facebook: 5 Facebook pages
googleplus: 1 Google+ user
reddit: 5 Redditors
bluesky: 1 Bluesky user

Readers on

mendeley: 419 Mendeley

So far, Altmetric has seen 5 posts from 4 blogs.

Study Suggests Effective Next-Step Treatments for Treatment-Resistant Depression

Psych News Alert, 08 Apr 2019

A new study of predictors and moderators of remission for treatment-resistant major depressive disorder (MDD) found two…

Scientists Clarify Risks of Augmenting with Antipsychotic Medications for Depression

Mad In America, 05 Dec 2017

When you get a diagnosis of depression, the first line treatment is often antidepressant medications. Unfortunately, initial…

Major depression study identifies greater improvement for ‘next step’ treatment

Vital Record, 09 Aug 2017

A clinical trial from Department of Veterans Affairs (VA) of veterans with major depressive disorder, published this month in…

Richard Lehman’s journal review—17 July 2017

Latest BMJ blogs, 17 Jul 2017

Richard Lehman reviews the latest research in the top medical…

This page shows the most recent blog posts that mention this research output. Click here to find out how to access more activity, including 1 additional blog posts.